Navigate Up
Sign In

NEWSROOM

 
​​
The module 1.4.1
MSD abides by Medicines Australia’s Code of Conduct and the Therapeutic Goods Act.
The module 1.5.1

​​Both prohibit a pharmaceutical company from direct to consumer advertising which includes issuing public press statements about our prescription medicines. We are able to issue public statements to advise registration of a new medicine, a reimbursement notice of a new medicine or any general corporate news not related to our medicines. For any specific issues please contact the communications manager
The module 1.5.2
.
The module 1.5.3
The module 1.5.1

 
The module 1.5.1

The module 1.4.3
The module 1.4.3 with Left image
The module 1.4.4
The module 1.4.7/1.4.8
 
The module 1.6.*

MEDIA

Tanya Holloway
Communications Manager
Phone: +61 407 695 885
Tanya.holloway@merck.com​​

The module 1.6.*

The module 1.6.*

  • This site is intended for Australian residents. MSD is a member of Medicines Australia. MSD recommends patients always seek the medical advice of their healthcare professional.